Drug intelligence / Profile preview

S-Butyryl-Cystein

Development stage: Unknown
Modality: Small Molecules

Overview

S-Butyryl-Cystein is a synthetic derivative of the amino acid cysteine, classified as an L-cysteine-S-conjugate. Its chemical structure consists of a cysteine backbone with a butyryl group attached to the sulfur atom. The compound has been explored for potential therapeutic applications, though it is not currently approved for any medical use and remains experimental. There are no reported clinical trials or approved indications as of now. The mechanism of action and specific pharmacological effects have not been well characterized in publicly available sources[1][2][3].

Other names: S-Butyryl-Cysteine

Beyond the preview

Go deeper on S-Butyryl-Cystein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-Butyryl-Cystein.

Explore the full profile